Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.
What Are Ozempic Burps? A Doctor Explains Everything You Need to Know About the Weird but Possible Side Effect
You have likely heard of Ozempic, since the miracle weight loss drug has been making headlines for quite some time now. Some ...
Yahoo Finance10h
Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers’ Target?
We recently published a list of 10 Worst Booming Stocks to Buy According to ... steatohepatitis and nonalcoholic fatty liver disease. Their VK2735 drug is a GLP-1 dual agonist being developed for ...
Does ‘nature’s Ozempic’ really work? Trendy GLP-1 supplements are designed to supercharge weight loss for a fraction of the price
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...
What Experts Think About Lemme's New GLP-1 Supplement
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
Becker's Spine Review23h
GLP-1s raise risk of infection in ankle procedures: Study
Patients prescribed glucagon-like peptide-1 agonists, including Ozepmic and Wegovy, have a significantly higher postoperative infection rate following ankle-fusion procedures, according to a Sept. 20 ...
Are GLP-1 supplements 'nature's Ozempic'? Doctors evaluate weight loss claims
GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help ...
InsideHook on MSN1d
Scientists Who Pioneered GLP-1 Drugs Honored With Lasker Award
Each year, the Lasker Awards honor a number of medical professionals doing standout work in research and public service. The ...